Medical term:
glucagon
glucagon
[gloo´kah-gon]glucagon
Pharmacologic class: Antihypoglycemic
Therapeutic class: Insulin antagonist
Pregnancy risk category B
Action
Increases blood glucose concentration by converting glycogen in liver to glucose. Also relaxes GI smooth muscle.
Availability
Powder for injection: 1-mg vials
Indications and dosages
➣ Severe hypoglycemia
Adults and children weighing more than 20 kg (44 lb): 1 mg subcutaneously, I.M., or I.V.
Children weighing 20 kg (44 lb) or less: 20 to 30 mcg/kg or 0.5-mg dose subcutaneously, I.M., or I.V.
➣ Diagnostic aid for radiologic examination
Adults: 0.25 to 2 mg I.V. or 1 to 2 mg I.M. before radiologic procedure
Contraindications
• Hypersensitivity to drug
• Pheochromocytoma
Precautions
Use cautiously in:
• cardiac disease, adrenal insufficiency, chronic hypoglycemia
• history suggesting insulinoma or pheochromocytoma
• elderly patients
• pregnant or breastfeeding patients.
Administration
☞ Use only in hypoglycemic emergencies for patients with diabetes mellitus.
• Mix drug in 1-mg vial with 1 ml of diluent supplied by manufacturer.
• For I.V. injection, give 1 mg over 1 minute.
• Use drug immediately after preparing; discard unused portion.
☞ Patient should respond within 15 minutes. Because of potential serious adverse reactions linked to prolonged cerebral hypoglycemia, give I.V. glucose if patient fails to respond to glucagon.
• Give patient carbohydrate-rich foods as soon as he's alert.
• Dilute diagnostic aid doses above 2 mg with sterile water for injection.
Adverse reactions
CV: hypotension
GI: nausea, vomiting
Metabolic: hypokalemia (with overdose)
Respiratory: bronchospasm, respiratory distress
Skin: urticaria, rash
Interactions
Drug-drug. Anticoagulants: enhanced anticoagulant effect
Drug-diagnostic tests. Potassium: decreased level
Patient monitoring
• Monitor blood glucose level.
• Monitor patient for aspiration.
• Assess blood pressure, electrolyte levels, and respiratory status.
Patient teaching
• Teach patient and family members the proper technique and timing for using this emergency drug.
☞ Emphasize importance of contacting prescriber right away if hypoglycemic emergency occurs.
☞ Tell caregiver or family member to arouse patient immediately and give additional carbohydrate by mouth as soon as patient can tolerate it.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above.
glu·ca·gon
(glū'kă-gon), [MIM*138030]glucagon
(glo͞o′kə-gŏn′)glucagon
Endocrinology A 29-residue polypeptide hormone, produced by pancreatic islet α cells that opposes insulin, activates hepatic phosphorylase, ↓ gastric motility, secretion and muscle mass, promotes glycogenolysis, ↑ serum glucose, ↑ ketogenesis and liver incorporation of amino acids and urinary excretion of Na+ and K+ ↑ in Neonates, glucagonoma, DM ↓ in Some Pts with DM, hypoglyecemiaglu·ca·gon
(glū'kă-gon)glucagon
One of the four hormones produced by the Islet cells of the PANCREAS, the others being insulin, somatostatin and a polypeptide of unknown function. The action of glucagon opposes that of insulin. It causes liver glycogen, a polysaccharide, to break down to glucose, thereby increasing the amount of sugar in the bloodstream. It can also mobilize fatty acids for energy purposes. Glucagon is a 20-amino acid peptide secreted by the alpha Islet cells. A brand name is Glucagen.glucagon
a polypeptide of 29 amino acids produced by the alpha cells in the ISLETS OF LANGERHANS of the pancreas of vertebrates. Glucagon acts as a hormone, having the opposite effect to INSULIN, in causing the breakdown of liver GLYCOGEN and the release of glucose into the blood.Glucagon
glu·ca·gon
(glū'kă-gon) [MIM*138030]glucagonoma
[gloo″kah-gon-o´mah]glu·ca·gon·o·ma
(glu'kă-gon-ō'mă),glucagonoma
A pancreatic alpha-cell tumour with 2 distinct clinicopathologic patterns:(1) Benign—not associated with glucagonoma syndrome, which has a bland, gyriform histology.
(2) Glucagon-producing neuroendocrine neoplasms of the pancreas, associated with the clinical syndrome of:
• Hyperglycaemia;
• Anaemia, diarrhoea, weight loss;
• Hypoaminoacidemia;
• Necrolytic migratory erythema.
Prognosis
Poor: up to 75% of glucagonoma patients die of disease.
glu·ca·gon·o·ma
(glu'kă-gon-ō'mă)Latest Searches:
Voraxaze - Voranil - Voorhoeve - voodoo - VOO - Vontrol - von - vomitus - vomiturition - vomitory - vomitoria - vomito - vomitive - vomiting - vomit - vomica - vomerovaginalis - vomerovaginal - vomerorostralis - vomerorostral -
- Service manuals - MBI Corp